Ally Bridge Group (Ny) LLC Xenon Pharmaceuticals Inc. Transaction History
Ally Bridge Group (Ny) LLC
- $88.1 Million
- Q4 2024
A detailed history of Ally Bridge Group (Ny) LLC transactions in Xenon Pharmaceuticals Inc. stock. As of the latest transaction made, Ally Bridge Group (Ny) LLC holds 129,291 shares of XENE stock, worth $4.72 Million. This represents 5.75% of its overall portfolio holdings.
Number of Shares
129,291
Previous 211,791
38.95%
Holding current value
$4.72 Million
Previous $8.33 Million
39.18%
% of portfolio
5.75%
Previous 5.92%
Shares
6 transactions
Others Institutions Holding XENE
# of Institutions
219Shares Held
70.4MCall Options Held
109KPut Options Held
2.1K-
Avoro Capital Advisors LLC New York, NY5.67MShares$207 Million3.24% of portfolio
-
Driehaus Capital Management LLC Chicago, IL4.52MShares$165 Million1.73% of portfolio
-
Wellington Management Group LLP Boston, MA3.78MShares$138 Million0.03% of portfolio
-
Braidwell LP Stamford, CT2.91MShares$106 Million6.4% of portfolio
-
Janus Henderson Group PLC London, X02.87MShares$105 Million0.06% of portfolio
About Xenon Pharmaceuticals Inc.
- Ticker XENE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,263,500
- Market Cap $2.27B
- Description
- Xenon Pharmaceuticals Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics to treat patients with neurological disorders in Canada. Its clinical development pipeline includes XEN496, A Kv7 potassium channel opener that is Phase III clinical trials for the treatment of KCNQ2 developmental and epilepsy encephalopath...